Rituximab-Based Therapy in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: Individualized Risk-Adapted Therapy Approach Using Molecular Subtypes

por Fan, Lei, Li, Lindong, Zhou, Yiqun, Li, Jianyong
Publicado 2017

Graded Heterojunction Improves Wide-Bandgap Perovskite for Highly Efficient 4-Terminal Perovskite/Silicon Tandem Solar Cells

por Chai, Wenming, Li, Lindong, Zhu, Weidong, Chen, Dazheng, Zhou, Long, Xi, He, Zhang, Jincheng, Zhang, Chunfu, Hao, Yue
Publicado 2023

Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese Subjects

por Li, Haiyan, Zhang, Weijiang, Petry, Claire, Li, Lindong, Fernandez, Elena, Kiialainen, Anna, Feng, Sheng, Hsu, Wanling, Li, Li, Wei, Yudong, Schmitt, Christophe
Publicado 2020

PB1929: EFFICACY AND SAFETY OF ACALABRUTINIB IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: AN OPEN-LABEL, MULTICENTER PHASE 1/2 TRIAL

por Yang, Shenmiao, Huang, Haiwen, Zhou, Keshu, Zhao, Xielan, Han#, Yan-Qiu, LI, Lindong, Butturini, Anna, Wang, Yiqiu, Liu, Xiaofeng, Lai, Peiqiong, LI, Jianyong
Publicado 2023

Prophylactic emicizumab for hemophilia A in the Asia‐Pacific region: A randomized study (HAVEN 5)

por Yang, Renchi, Wang, Shujie, Wang, Xuefeng, Sun, Jing, Chuansumrit, Ampaiwan, Zhou, Jianfeng, Schmitt, Christophe, Hsu, Wanling, Xu, Jeffrey, Li, Lindong, Chang, Tiffany, Zhao, Xielan
Publicado 2022

Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab

por Hsu, Chiun, Ducreux, Michel, Zhu, Andrew X., Qin, Shukui, Ikeda, Masafumi, Kim, Tae-You, Galle, Peter R., Finn, Richard S., Chen, Ethan, Ma, Ning, Hu, Youyou, Li, Lindong, Cheng, Ann-Lii
Publicado 2022